Case Control Study
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 26, 2023; 11(18): 4267-4276
Published online Jun 26, 2023. doi: 10.12998/wjcc.v11.i18.4267
Multimodal integrated intervention for children with attention-deficit/hyperactivity disorder
Ying-Bo Lv, Wei Cheng, Meng-Hui Wang, Xiao-Min Wang, Yan-Li Hu, Lan-Qiu Lv
Ying-Bo Lv, Wei Cheng, Meng-Hui Wang, Xiao-Min Wang, Yan-Li Hu, Lan-Qiu Lv, Pediatric Health Care Section, Ningbo Women and Children's Hospital, Ningbo 315000, Zhejiang Province, China
Author contributions: Lv YB and Cheng W proposed the concept of this study; Wang MH and Lv LQ contributed to data collection; Lv YB, Wang XM, and Hu YL contributed to formal analysis; Lv YB and Lv LQ contributed to the survey; Lv YB, Lv LQ, and Wang XM contributed to the methods; Lv YB, Lv LQ, Hu YL, and Wang MH supervised the study; Lv LQ validated the study; Lv YB and Cheng W contributed to visualization of the study; Lv YB and Lv LQ wrote the initial draft of the manuscript; and Lv YB, Cheng W, Wang MH, and Wang XM reviewed and edited the manuscript.
Supported by Ningbo Medical Key Fostering Discipline Child Health Science, No. 2022-F26; Ningbo Science and Technology Plan Project Public Welfare Plan, No. 2019C50099.
Institutional review board statement: The authors declare that every effort has been made to comply with all local and international ethical standards and laws related to the study. This study was conducted in accordance with the Helsinki Declaration and approved by the Institutional Review Committee of Zhejiang Ningbo Women and Children's Hospital (No. NBFY2020093).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The author declares that there is no interest relationship.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement, and the manuscript was prepared and revised according to the STROBE Statement.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Lan-Qiu Lv, MD, Attending Doctor, Pediatric Health Care Section, Ningbo Women and Children's Hospital, No. 339 Liuting Street, Haishu District, Ningbo 315000, Zhejiang Province, China. lulanqiunb@sina.com
Received: April 11, 2023
Peer-review started: April 11, 2023
First decision: April 26, 2023
Revised: May 4, 2023
Accepted: May 19, 2023
Article in press: May 19, 2023
Published online: June 26, 2023
Abstract
BACKGROUND

Attention-deficit/hyperactivity disorder (ADHD) is one of the most common disorders in child and adolescent psychiatry, with a prevalence of more than 5%. Despite extensive research on ADHD in the last 10 to 20 years, effective treat-ments are still lacking. Instead, the concept of ADHD seems to have become broader and more heterogeneous. Therefore, the diagnosis and treatment of ADHD remains challenging for clinicians.

AIM

To investigate the effects of a multimodal integrated intervention for children with ADHD.

METHODS

Between March 2019 and September 2020, a total of 100 children with ADHD who were diagnosed and treated at our hospital were assessed for eligibility, two of whom revoked their consent. A case-control study was conducted in which the children were equally assigned, using a randomized number table, to either a medication group (methylphenidate hydrochloride extended-release tablets and atomoxetine hydrochloride tablets) or a multimodal integrated intervention group (medication + parent training + behavior modification + sensory integration therapy + sand tray therapy), with 49 patients in each group. The clinical endpoint was the efficacy of the different intervention modalities.

RESULTS

The two groups of children with ADHD had comparable patient characteristics (P > 0.05). Multimodal integrated intervention resulted in a significantly higher treatment efficacy (91.84%) than medication alone (75.51%) (P < 0.05). Children who received the multimodal integrated intervention showed lower scores in the Conners Parent Symptom Questionnaire and the Weiss Functional Impairment Rating Scale than those treated with medication alone (P < 0.05). The Sensory Integration Scale scores of children in the multimodal integrated intervention group were higher than those of children in the medication group (P < 0.05). Children who received the multimodal integrated intervention had higher compliance and family satisfaction and a lower incidence of adverse events than those treated with medication alone (P < 0.05).

CONCLUSION

Multimodal integrated intervention effectively alleviated symptoms associated with ADHD in children. It enhanced their memory and attention with high safety and parental satisfaction, demonstrating good potential for clinical promotion.

Keywords: Attention-deficit/hyperactivity disorder, Multimodal integrated intervention, Medication, Behavior modification, Sensory integration therapy, Sand tray therapy

Core Tip: Multimodal integrated intervention, including medication, parent training, behavior modification, sensory integration therapy, and sand tray therapy, has been shown to effectively alleviate symptoms of attention-deficit/hyperactivity disorder (ADHD) in children. This intervention resulted in higher treatment efficacy compared to medication alone, with lower scores in symptom questionnaires and functional impairment scales. Children who received this approach also had higher compliance and family satisfaction and a lower incidence of adverse events. Such a multimodal integrated intervention shows promising potential for clinical promotion in ADHD treatment.